Veeva Systems (NYSE:VEEV – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $208.00 to $218.00 in a report published on Monday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the technology company’s stock.
A number of other brokerages have also recently issued reports on VEEV. Scotiabank raised their price objective on Veeva Systems from $235.00 to $240.00 and gave the company a “sector perform” rating in a research note on Friday, December 6th. Needham & Company LLC raised their price target on Veeva Systems from $260.00 to $270.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Truist Financial reiterated a “hold” rating and issued a $261.00 price objective (up previously from $207.00) on shares of Veeva Systems in a research report on Friday, December 6th. StockNews.com raised Veeva Systems from a “hold” rating to a “buy” rating in a research note on Saturday, November 9th. Finally, Barclays lifted their target price on shares of Veeva Systems from $260.00 to $275.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eighteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $255.73.
Check Out Our Latest Report on Veeva Systems
Veeva Systems Stock Performance
Insider Activity
In other Veeva Systems news, insider Thomas D. Schwenger sold 1,126 shares of Veeva Systems stock in a transaction on Friday, November 8th. The stock was sold at an average price of $240.01, for a total transaction of $270,251.26. Following the completion of the transaction, the insider now owns 27,013 shares in the company, valued at approximately $6,483,390.13. The trade was a 4.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Jonathan Faddis sold 1,694 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $230.30, for a total value of $390,128.20. Following the completion of the sale, the senior vice president now directly owns 8,061 shares in the company, valued at approximately $1,856,448.30. This represents a 17.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 10.50% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the company. Mowery & Schoenfeld Wealth Management LLC bought a new stake in Veeva Systems in the 3rd quarter worth about $26,000. True Wealth Design LLC boosted its holdings in shares of Veeva Systems by 3,375.0% during the 3rd quarter. True Wealth Design LLC now owns 139 shares of the technology company’s stock valued at $29,000 after acquiring an additional 135 shares during the last quarter. Blue Trust Inc. grew its stake in shares of Veeva Systems by 3,460.0% in the second quarter. Blue Trust Inc. now owns 178 shares of the technology company’s stock worth $33,000 after acquiring an additional 173 shares during the period. DT Investment Partners LLC bought a new position in Veeva Systems during the second quarter valued at approximately $35,000. Finally, Harvest Fund Management Co. Ltd bought a new position in Veeva Systems during the third quarter valued at approximately $49,000. 88.20% of the stock is owned by hedge funds and other institutional investors.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
See Also
- Five stocks we like better than Veeva Systems
- Dividend Payout Ratio Calculator
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Stock Dividend Cuts Happen Are You Ready?
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Health Care Stocks Explained: Why You Might Want to Invest
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.